Lactobacillus plantarum – LP02 (LMG P-21020)

    Gastroenterology strain | Antipathogenic activity

    Characteristics

    FUNCTIONALITY
    Inhibition of E. coli

    Scientific support

    In vitro studies
    Mogna L. et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains. J Clin Gastroenterol. 2012; 46 Suppl:S29-32.


    Immunology blend | Immune stimulation

    • Lactobacillus rhamnosus – LR04 (DSM 16605)
    • Lactobacillus rhamnosus – LR05 (DSM 19739)
    • Lactobacillus plantarum – LP01 (LMG P-21021)
    • Lactobacillus plantarum – LP02 (LMG P-21020)
    • Bifidobacterium animalis subsp. lactis – BS01 (LMG P-21384)

    Characteristics

    DAILY DOSAGE IN CLINICAL STUDY
    2.5 billion CFU + 2.5 billion CFU + 2.5 billion CFU + 2.5 billion CFU + 5 billion CFU + FOS or GOS

    FUNCTIONALITY
    Reinforcement of the natural defences • Reduction of the intestinal discomfort • Rebalance of the intestinal microbiota

    Scientific support

    Human clinical trial
    1) Pregliasco F. et al. A New Chance of Preventing Winter Diseases by the Administration of Symbiotic Formulations. Journal of Clinical Gastroenterology, 2008; 42(2): 224-233.
    2) Belcaro G. et al. Prevention of flu episodes with colostrum and Bifivir compared with vaccination: an epidemiological, registry study. Panminerva Medica 2010;52:269-75.

    In vitro study
    Mogna L. et al. Micronized Cells of the Probiotic Strain Bifidobacterium lactis BS01 Activate Monocyte Polarization: A New Approach. J Clin Gastroenterol. 2018;52:S57-S61.

    + Internal data on immune stimulation and anti-pathogen activity available upon request for certain strains


    Immunology blend | Immune stimulation

    • Bifidobacterium animalis subsp. lactis – BS01 (LMG P-21384)
    • Lactobacillus rhamnosus – LR04 (DSM 16605)
    • Lactobacillus plantarum – LP02 (LMG P-21020)

    Characteristics

    DAILY DOSAGE IN CLINICAL STUDY
    10 billion CFU + 10 billion CFU + 10 billion CFU + 3g

    FUNCTIONALITY
    Reinforcement of the natural defences • Reduction of the incidence, severity and duration of Acute Respiratory Infections (ARI) during the cold season

    Scientific support

    Human clinical trial
    Pregliasco F. et al. A New Chance of Preventing Winter Diseases by the Administration of Symbiotic Formulations. Journal of Clinical Gastroente- rology, 2008; 42(2): 224-233.

    In vitro study
    Mogna L. et al. Micronized Cells of the Probiotic Strain Bifidobacterium lactis BS01 Activate Monocyte Polarization: A New Approach. J Clin Ga- stroenterol. 2018;52:S57-S61.

    + Internal data on immune stimulation and anti-pathogen activity available upon request for certain strains


    Gynecology blend | Vaginal candidiasis – Bacterial vaginosis

    • Lactobacillus plantarum – LP02 (LLMG P-21020)
    • Lactobacillus fermentum – LF10 (DSM 19187)

    Characteristics

    DAILY DOSAGE IN CLINICAL STUDY
    500 million per strain

    FUNCTIONALITY
    Vaginal health • Counteraction of Candida vulvovaginitis • Counteraction of Candida vulvovaginitis including recurrence

    Scientific support

    Clinical study
    Murina F. et al. Thymol, eugenol and lactobacilli in a medical device for the treatment of bacterial vaginosis and vulvovaginal candidiasis. New Microbiologica, 41,3, 220-224, 2018, ISN 1121-7138.


    Urology strain | Antipathogenic activity

    Characteristics

    FUNCTIONALITY
    Cystitis • Inhibition of E. coli

    Scientific support

    In vitro studies
    Mogna L. et al. Assessment of the in vitro inhibitory activity of specific probiotic bacteria against different Escherichia coli strains (LP01, LP02, LR04, LR06, LPS01, LDD01, BR03, B632). J Clin Gastroenterol. 2012; 46 Suppl:S29-32.

    + Internal data on anti-inflammatory and anti-oxidant properties available upon request for some of these strains